Sumanta K. Pal: Will be interesting to apply the TOPOSCORE to existing cohorts

Sumanta K. Pal shared a post on X:    .

“Terrific work Lisa Derosa & team. I found this paragraph particularly helpful in understanding the approach. Will be interesting to apply the TOPOSCORE to existing cohorts and better understand the extent of dysbiosis in some of our trials at City of Hope.”

Source: Sumanta K. Pal/X

Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.